{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:44:47Z","timestamp":1764791087208,"version":"3.46.0"},"reference-count":59,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>The steady rise in the incidence of cutaneous malignant melanoma and its inherently difficult-to-interpret histopathology continues to fuel an increasing demand for diagnostically and prognostically insightful adjunctive molecular tests among both clinicians and dermatopathologists. A number of DNA, RNA, and epigenetically based assays have now been developed and are at various stages of experimental and\/or clinical use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective.\u2014<\/jats:title>\n                    <jats:p>To examine the evidence for the utility and limitations of these leading candidates for the diagnosis and risk stratification of melanoma and related melanocytic neoplasms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Sources.\u2014<\/jats:title>\n                    <jats:p>The available English medical literature was reviewed in the preparation of this manuscript.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>Comparative genomic hybridization, fluorescence in situ hybridization, RNA-based gene expression profiling, and immunohistochemical assays for novel genetic and epigenetic markers will help bring diagnostic and prognostic accuracy to the assessment of melanocytic neoplasms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2018-0038-ra","type":"journal-article","created":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T11:29:33Z","timestamp":1540380573000},"page":"811-820","source":"Crossref","is-referenced-by-count":16,"title":["Molecular Testing for Cutaneous Melanoma: An Update and Review"],"prefix":"10.5858","volume":"143","author":[{"given":"Jonathan J.","family":"Lee","sequence":"first","affiliation":[{"name":"From the Department of Dermatology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania (Dr Lee); and the Program in Dermatopathology, Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Drs Lee and Lian)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine G.","family":"Lian","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania (Dr Lee); and the Program in Dermatopathology, Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Drs Lee and Lian)."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3906","published-online":{"date-parts":[[2018,10,24]]},"reference":[{"author":"American Cancer Society","key":"2020081203302553400_i1543-2165-143-7-811-b01","article-title":"Key statistics for melanoma skin cancer"},{"issue":"3","key":"2020081203302553400_i1543-2165-143-7-811-b02","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/PAS.0b013e3181cf7fa0","article-title":"Melanocytic tumors of uncertain malignant potential: results of a tutorial held at the XXIX Symposium of the International Society of Dermatopathology in Graz, October 2008","volume":"34","author":"Cerroni","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"2020081203302553400_i1543-2165-143-7-811-b03","doi-asserted-by":"crossref","first-page":"j2813","DOI":"10.1136\/bmj.j2813","article-title":"Pathologists' diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study","volume":"357","author":"Elmore","year":"2017","journal-title":"BMJ"},{"issue":"7","key":"2020081203302553400_i1543-2165-143-7-811-b04","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/PAS.0000000000000198","article-title":"Histomorphologic assessment and interobserver diagnostic reproducibility of atypical spitzoid melanocytic neoplasms with long-term follow-up","volume":"38","author":"Gerami","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"2020081203302553400_i1543-2165-143-7-811-b05","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/cup.12566","article-title":"BAM!: utilizing the frequency of benign, atypical and malignant diagnoses for quality improvement in the histopathologic diagnosis of melanocytic neoplasms","volume":"42","author":"Bush","year":"2015","journal-title":"J Cutan Pathol"},{"issue":"4","key":"2020081203302553400_i1543-2165-143-7-811-b06","doi-asserted-by":"crossref","first-page":"615","DOI":"10.5858\/2007-131-615-TMAOEI","article-title":"The medicolegal aspect of error in pathology: a search of jury verdicts and settlements","volume":"131","author":"Kornstein","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"2020081203302553400_i1543-2165-143-7-811-b07","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejca.2017.10.031","article-title":"Improved stratification of pT1 melanoma according to the 8th American Joint Committee on Cancer staging edition criteria: a Dutch population-based study","volume":"92","author":"Verver","year":"2018","journal-title":"Eur J Cancer"},{"issue":"6","key":"2020081203302553400_i1543-2165-143-7-811-b08","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3322\/caac.21409","article-title":"Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"2020081203302553400_i1543-2165-143-7-811-b09","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/his.13060","article-title":"Breslow density is a novel prognostic feature in cutaneous malignant melanoma","volume":"70","author":"Rashed","year":"2017","journal-title":"Histopathology"},{"issue":"6","key":"2020081203302553400_i1543-2165-143-7-811-b10","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/cup.12705","article-title":"The self-reported use of immunostains and cytogenetic testing in the diagnosis of melanoma by practicing U.S. pathologists of 10 selected states","volume":"43","author":"Zhao","year":"2016","journal-title":"J Cutan Pathol"},{"issue":"1","key":"2020081203302553400_i1543-2165-143-7-811-b11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/DAD.0000000000000909","article-title":"Educational gaps in molecular diagnostics, genomics, and personalized medicine in dermatopathology training: a survey of U.S. dermatopathology fellowship program directors","volume":"40","author":"Torre","year":"2018","journal-title":"Am J Dermatopathol"},{"issue":"2","key":"2020081203302553400_i1543-2165-143-7-811-b12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0165-4608(92)90336-7","article-title":"Translocation t(12;22)(q13;q13) is a nonrandom rearrangement in clear cell sarcoma","volume":"64","author":"Reeves","year":"1992","journal-title":"Cancer Genet Cytogenet"},{"key":"2020081203302553400_i1543-2165-143-7-811-b13","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1038\/ncomms4116","article-title":"Kinase fusions are frequent in Spitz tumours and spitzoid melanomas","volume":"5","author":"Wiesner","year":"2014","journal-title":"Nat Commun"},{"issue":"5","key":"2020081203302553400_i1543-2165-143-7-811-b14","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/PAS.0000000000000160","article-title":"Comparative analysis of atypical Spitz tumors with heterozygous versus homozygous 9p21 deletions for clinical outcomes, histomorphology, BRAF mutation, and p16 expression","volume":"38","author":"Yazdan","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"2020081203302553400_i1543-2165-143-7-811-b15","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/PAS.0b013e3182753de6","article-title":"Risk assessment for atypical spitzoid melanocytic neoplasms using FISH to identify chromosomal copy number aberrations","volume":"37","author":"Gerami","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"2020081203302553400_i1543-2165-143-7-811-b16","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/PAS.0b013e318222a634","article-title":"Assessment of copy number status of chromosomes 6 and 11 by FISH provides independent prognostic information in primary melanoma","volume":"35","author":"North","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"2020081203302553400_i1543-2165-143-7-811-b17","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/archdermatol.2009.386","article-title":"Sensitivity of fluorescence in situ hybridization for melanoma diagnosis using RREB1, MYB, Cep6, and 11q13 probes in melanoma subtypes","volume":"146","author":"Gerami","year":"2010","journal-title":"Arch Dermatol"},{"issue":"4","key":"2020081203302553400_i1543-2165-143-7-811-b18","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/00313020902915875","article-title":"Diagnosis of cutaneous melanocytic tumours by four-colour fluorescence in situ hybridisation","volume":"41","author":"Morey","year":"2009","journal-title":"Pathology"},{"issue":"5","key":"2020081203302553400_i1543-2165-143-7-811-b19","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/modpathol.2010.228","article-title":"Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 cases","volume":"24","author":"Vergier","year":"2011","journal-title":"Mod Pathol"},{"issue":"3","key":"2020081203302553400_i1543-2165-143-7-811-b20","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/modpathol.2009.177","article-title":"Classifying ambiguous melanocytic lesions with FISH and correlation with clinical long-term follow up","volume":"23","author":"Gaiser","year":"2010","journal-title":"Mod Pathol"},{"issue":"3","key":"2020081203302553400_i1543-2165-143-7-811-b21","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.cll.2017.06.002","article-title":"Molecular melanoma diagnosis update: gene fusion, genomic hybridization, and massively parallel short-read sequencing","volume":"37","author":"Lang","year":"2017","journal-title":"Clin Lab Med"},{"issue":"5083","key":"2020081203302553400_i1543-2165-143-7-811-b22","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.1359641","article-title":"Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors","volume":"258","author":"Kallioniemi","year":"1992","journal-title":"Science"},{"issue":"5","key":"2020081203302553400_i1543-2165-143-7-811-b23","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/S0002-9440(10)63536-5","article-title":"Classifying melanocytic tumors based on DNA copy number changes","volume":"163","author":"Bastian","year":"2003","journal-title":"Am J Pathol"},{"issue":"10","key":"2020081203302553400_i1543-2165-143-7-811-b24","first-page":"2170","article-title":"Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization","volume":"58","author":"Bastian","year":"1998","journal-title":"Cancer Res"},{"issue":"13","key":"2020081203302553400_i1543-2165-143-7-811-b25","first-page":"2765","article-title":"Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms","volume":"57","author":"Mertens","year":"1997","journal-title":"Cancer Res"},{"issue":"4","key":"2020081203302553400_i1543-2165-143-7-811-b26","first-page":"645","article-title":"Genetics of melanoma","volume":"9","author":"Fountain","year":"1990","journal-title":"Cancer Surv"},{"issue":"2","key":"2020081203302553400_i1543-2165-143-7-811-b27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/PAS.0b013e31820393ee","article-title":"Copy number variations and clinical outcome in atypical Spitz tumors","volume":"35","author":"Raskin","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"2020081203302553400_i1543-2165-143-7-811-b28","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/DAD.0b013e3181b96db7","article-title":"Molecular analysis of a case of nevus of Ota showing progressive evolution to melanoma with intermediate stages resembling cellular blue nevus","volume":"32","author":"Gerami","year":"2010","journal-title":"Am J Dermatopathol"},{"issue":"5","key":"2020081203302553400_i1543-2165-143-7-811-b29","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/PAS.0000000000000387","article-title":"Clinical, histopathologic, and genomic features of Spitz tumors with ALK fusions","volume":"39","author":"Yeh","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"2020081203302553400_i1543-2165-143-7-811-b30","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1158\/1078-0432.CCR-13-3316","article-title":"Development of a prognostic genetic signature to predict the metastatic risk associated with cutaneous melanoma","volume":"21","author":"Gerami","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"5","key":"2020081203302553400_i1543-2165-143-7-811-b31","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.jaad.2015.01.009","article-title":"Gene expression profiling for molecular staging of cutaneous melanoma in patients undergoing sentinel lymph node biopsy","volume":"72","author":"Gerami","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"2020081203302553400_i1543-2165-143-7-811-b32","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1158\/1055-9965.EPI-16-0958","article-title":"Diagnostic distinction of malignant melanoma and benign nevi by a gene expression signature and correlation to clinical outcomes","volume":"26","author":"Ko","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"2020081203302553400_i1543-2165-143-7-811-b33","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/cncr.30385","article-title":"An independent validation of a gene expression signature to differentiate malignant melanoma from benign melanocytic nevi","volume":"123","author":"Clarke","year":"2017","journal-title":"Cancer"},{"issue":"4","key":"2020081203302553400_i1543-2165-143-7-811-b34","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/cup.12475","article-title":"Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanoma","volume":"42","author":"Clarke","year":"2015","journal-title":"J Cutan Pathol"},{"key":"2020081203302553400_i1543-2165-143-7-811-b35","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.humpath.2017.10.005","article-title":"Gene expression signature as an ancillary method in the diagnosis of desmoplastic melanoma","volume":"70","author":"Clarke","year":"2017","journal-title":"Hum Pathol"},{"issue":"8","key":"2020081203302553400_i1543-2165-143-7-811-b36","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/modpathol.2016.84","article-title":"Comparison between melanoma gene expression score and fluorescence in situ hybridization for the classification of melanocytic lesions","volume":"29","author":"Minca","year":"2016","journal-title":"Mod Pathol"},{"issue":"7","key":"2020081203302553400_i1543-2165-143-7-811-b37","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1001\/jamadermatol.2017.0473","article-title":"Utility of a noninvasive 2-gene molecular assay for cutaneous melanoma and effect on the decision to biopsy","volume":"153","author":"Ferris","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"1","key":"2020081203302553400_i1543-2165-143-7-811-b38","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jaad.2016.07.038","article-title":"Development and validation of a noninvasive 2-gene molecular assay for cutaneous melanoma","volume":"76","author":"Gerami","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"2020081203302553400_i1543-2165-143-7-811-b39","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/PAS.0b013e3182498be5","article-title":"A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression","volume":"36","author":"Wiesner","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"2020081203302553400_i1543-2165-143-7-811-b40","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/ng.910","article-title":"Germline mutations in BAP1 predispose to melanocytic tumors","volume":"43","author":"Wiesner","year":"2011","journal-title":"Nat Genet"},{"issue":"6009","key":"2020081203302553400_i1543-2165-143-7-811-b41","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1194472","article-title":"Frequent mutation of BAP1 in metastasizing uveal melanomas","volume":"330","author":"Harbour","year":"2010","journal-title":"Science"},{"issue":"2","key":"2020081203302553400_i1543-2165-143-7-811-b42","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/DAD.0b013e31828a2d54","article-title":"Epigenetic modifications in cutaneous malignant melanoma: EZH2, H3K4me2, and H3K27me3 immunohistochemical expression is enhanced at the invasion front of the tumor","volume":"37","author":"Kampilafkos","year":"2015","journal-title":"Am J Dermatopathol"},{"issue":"10","key":"2020081203302553400_i1543-2165-143-7-811-b43","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1016\/j.celrep.2016.11.032","article-title":"Deletion of the polycomb-group protein EZH2 leads to compromised self-renewal and differentiation defects in human embryonic stem cells","volume":"17","author":"Collinson","year":"2016","journal-title":"Cell Rep"},{"issue":"1","key":"2020081203302553400_i1543-2165-143-7-811-b44","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/modpathol.2015.134","article-title":"Loss of H3K27 trimethylation distinguishes malignant peripheral nerve sheath tumors from histologic mimics","volume":"29","author":"Schaefer","year":"2016","journal-title":"Mod Pathol"},{"issue":"8","key":"2020081203302553400_i1543-2165-143-7-811-b45","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/labinvest.2014.87","article-title":"Melanoma epigenetics: novel mechanisms, markers, and medicines","volume":"94","author":"Lee","year":"2014","journal-title":"Lab Invest"},{"issue":"8","key":"2020081203302553400_i1543-2165-143-7-811-b46","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/j.celrep.2016.04.058","article-title":"Tet enzymes regulate telomere maintenance and chromosomal stability of mouse ESCs","volume":"15","author":"Yang","year":"2016","journal-title":"Cell Rep"},{"issue":"6","key":"2020081203302553400_i1543-2165-143-7-811-b47","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.celrep.2016.01.035","article-title":"5-Hydroxymethylcytosine marks sites of DNA damage and promotes genome stability","volume":"14","author":"Kafer","year":"2016","journal-title":"Cell Rep"},{"issue":"3","key":"2020081203302553400_i1543-2165-143-7-811-b48","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/CMR.0b013e32835f9bd4","article-title":"Loss of 5-hydroxymethylcytosine and ten-eleven translocation 2 protein expression in malignant melanoma","volume":"23","author":"Gambichler","year":"2013","journal-title":"Melanoma Res"},{"issue":"8","key":"2020081203302553400_i1543-2165-143-7-811-b49","doi-asserted-by":"crossref","first-page":"627","DOI":"10.18632\/oncotarget.316","article-title":"Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem\/progenitor cell compartments and in human cancers","volume":"2","author":"Haffner","year":"2011","journal-title":"Oncotarget"},{"issue":"6","key":"2020081203302553400_i1543-2165-143-7-811-b50","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.cell.2012.07.033","article-title":"Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma","volume":"150","author":"Lian","year":"2012","journal-title":"Cell"},{"issue":"12","key":"2020081203302553400_i1543-2165-143-7-811-b51","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1016\/j.jid.2016.07.015","article-title":"5-Hydroxymethylcytosine expression in proliferative nodules arising within congenital nevi allows differentiation from malignant melanoma","volume":"136","author":"Pavlova","year":"2016","journal-title":"J Invest Dermatol"},{"issue":"11","key":"2020081203302553400_i1543-2165-143-7-811-b52","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/cup.12564","article-title":"Diagnostic utility of 5-hydroxymethylcytosine immunohistochemistry in melanocytic proliferations","volume":"42","author":"Rodic","year":"2015","journal-title":"J Cutan Pathol"},{"issue":"2","key":"2020081203302553400_i1543-2165-143-7-811-b53","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jdermsci.2013.09.008","article-title":"5-Hydroxymethylcytosine as a useful marker to differentiate between malignant melanomas and benign melanocytic nevi","volume":"73","author":"Uchiyama","year":"2014","journal-title":"J Dermatol Sci"},{"issue":"1","key":"2020081203302553400_i1543-2165-143-7-811-b54","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/modpathol.2016.159","article-title":"5-Hydroxymethylcytosine is an independent predictor of survival in malignant melanoma","volume":"30","author":"Saldanha","year":"2017","journal-title":"Mod Pathol"},{"issue":"35","key":"2020081203302553400_i1543-2165-143-7-811-b55","doi-asserted-by":"crossref","first-page":"37995","DOI":"10.18632\/oncotarget.6062","article-title":"Loss of the epigenetic mark, 5-hydroxymethylcytosine, correlates with small cell\/nevoid subpopulations and assists in microstaging of human melanoma","volume":"6","author":"Lee","year":"2015","journal-title":"Oncotarget"},{"issue":"3","key":"2020081203302553400_i1543-2165-143-7-811-b56","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/cup.12880","article-title":"5-Hydroxymethylcytosine is a nuclear biomarker to assess biological potential in histologically ambiguous heavily pigmented melanocytic neoplasms","volume":"44","author":"Lee","year":"2017","journal-title":"J Cutan Pathol"},{"issue":"2","key":"2020081203302553400_i1543-2165-143-7-811-b57","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/modpathol.2014.99","article-title":"5-Hydroxymethylcytosine expression in metastatic melanoma versus nodal nevus in sentinel lymph node biopsies","volume":"28","author":"Lee","year":"2014","journal-title":"Mod Pathol"},{"issue":"7","key":"2020081203302553400_i1543-2165-143-7-811-b58","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1097\/PAS.0000000000000848","article-title":"A novel numerical scoring system for melanoma tumor-infiltrating lymphocytes has better prognostic value than standard scoring","volume":"41","author":"Saldanha","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"2020081203302553400_i1543-2165-143-7-811-b59","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jmoldx.2013.04.001","article-title":"A genome-wide high-resolution array CGH analysis of cutaneous melanoma and comparison of array-CGH to FISH in diagnostic evaluation","volume":"15","author":"Wang","year":"2013","journal-title":"J Mol Diagn"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/143\/7\/811\/2501228\/arpa_2018-0038-ra.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/143\/7\/811\/2501228\/arpa_2018-0038-ra.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:36:08Z","timestamp":1764790568000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/143\/7\/article-p811.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,24]]},"references-count":59,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,10,24]]},"published-print":{"date-parts":[[2019,7,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2018-0038-ra","relation":{},"ISSN":["0003-9985","1543-2165"],"issn-type":[{"type":"print","value":"0003-9985"},{"type":"electronic","value":"1543-2165"}],"subject":[],"published":{"date-parts":[[2018,10,24]]}}}